Provider response to a rare but highly publicized transmission of HIV through solid organ transplantation

Archives of Surgery

Volumn 146, Issue 1, 2011, Pages 41-45

  Kucirka, Lauren M ^a   Ros, R Lorie ^a   Subramanian, Aruna K ^a   Montgomery, Robert A ^a   Segev, Dorry L ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEIC ACID;

ARTICLE; CLINICAL PRACTICE; DISEASE TRANSMISSION; HEALTH CARE POLICY; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ORGAN TRANSPLANTATION; PATIENT SAFETY; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; SURGEON;

ATTITUDE OF HEALTH PERSONNEL; DATA COLLECTION; HEPATITIS C; HIV INFECTIONS; HUMANS; ORGAN TRANSPLANTATION; PHYSICIAN'S PRACTICE PATTERNS; RISK FACTORS; TISSUE DONORS;

EID: 78751686428     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.2010.303     Document Type: Article

References (15)

1. Grady D. Four transplant recipients contract HIV. http://www.nytimes.com/ 2007/11/13/health/13cnd-organ.html?r=1&em&ex=1195189200&en= 4aa09291f000fe7b%ei=5087%0A. Accessed November 15, 2010.
2. Halpern SD, Shaked A, Hasz RD, Caplan AL. Informing candidates for solid-organ transplantation about donor risk factors. N Engl J Med. 2008;358(26): 2832-2837.
3. Provisional Public Health Service interagency recommendations for screening donated blood and plasma for antibody to the virus causing acquired immunodeficiency syndrome. http://www.cdc.gov/mmwr/preview/mmwrhtml/00033029. htm. Accessed September 12, 2008.
4. Rogers MS, Lawton KE, Moseley RR; Centers for Disease Control and Prevention. Guidelines for preventing transmission of human immunodeficiency virus through transplantation of human organs.MMWRMorb Mortal Wkly Rep. 1994; 43(RR-8):1-17.
5. Ahn J, Cohen SM. Transmission of human immunodeficiency virus and hepatitis C virus through liver transplantation. Liver Transpl. 2008;14(11):1603-1608.
6. Freeman RB, Cohen JT. Transplantation risks and the real world: what does "high risk" really mean? Am J Transplant. 2009;9(1):23-30.
7. Kucirka LM, Alexander C, Namuyinga R, Hanrahan C, Montgomery RA, Segev DL. Viral nucleic acid testing (NAT) and OPO-level disposition of high-risk donor organs. Am J Transplant. 2009;9(3):620-628.
8. Schweitzer EJ, Perencevich EN, Philosophe B, Bartlett ST. Estimated benefits of transplantation of kidneys from donors at increased risk for HIV or hepatitis C infection. Am J Transplant. 2007;7(6):1515-1525.
9. Studdert DM, Mello MM, Sage WM, et al. Defensive medicine among high-risk specialist physicians in a volatile malpractice environment. JAMA. 2005;293 (21):2609-2617.
10. Ljunggren D. Canada tightens rules governing organ donation. Reuters Canada Web site. http://ca.reuters.com/article/topNews/idCAN0849820220080108. Accessed June 18, 2008.
11. United Network for Organ Sharing. Communication of donor history. United Network for Organ Sharing Web site. http://optn.transplant.hrsa.gov /PoliciesandBylaws2/policies/pdfs/policy-16.pdf. Accessed November 11, 2010.
12. Kusne S. Regarding unexpected severe and life-threatening donor-transmitted viral infections and use of high-risk behavior donors. Liver Transpl. 2008;14 (11):1564-1568.
13. Singer AL, Kucirka LM, Namuyinga RHC, Hanrahan C, Subramanian AK, Segev DL. The high-risk donor: viral infections in solid organ transplantation. Curr Opin Organ Transplant. 2008;13(4):400-404.
14. Kucirka LM, Namuyinga R, Hanrahan C, Montgomery RA, Segev DL. Formal policies and special informed consent are associated with higher provider utilization of CDC high-risk donor organs. Am J Transplant. 2009;9(3):629-635.
15. Kucirka LM, Namuyinga R, Hanrahan C, Montgomery RA, Segev DL. Provider utilization of high-risk donor organs and nucleic acid testing: results of two national surveys. Am J Transplant. 2009;9(5):1197-1204.